Bioceres Crop Solutions Corp. $BIOX Shares Sold by Ardsley Advisory Partners LP

Key Points

• Ardsley Advisory Partners LP sold 116,000 shares of Bioceres Crop Solutions Corp., reducing its stake by 10.9% to 948,614 shares, valued at approximately $4.33 million.
• Despite Ardsley's reduction, other hedge funds like Fourth Sail Capital LP and Maven Securities LTD significantly increased their holdings in Bioceres during the same quarter.
• Equities analysts have mixed opinions on Bioceres, with rating adjustments including a downgrade to "hold" by Brookline Capital Management and a newly raised consensus target price of $8.38.

Ardsley Advisory Partners LP decreased its holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 10.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 948,614 shares of the company's stock after selling 116,000 shares during the quarter. Ardsley Advisory Partners LP owned about 1.51% of Bioceres Crop Solutions worth $4,330,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in BIOX. Bank of America Corp DE boosted its position in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after purchasing an additional 3,735 shares in the last quarter. Avanza Fonder AB purchased a new position in Bioceres Crop Solutions in the 1st quarter worth $72,000. PDT Partners LLC purchased a new position in Bioceres Crop Solutions in the 1st quarter worth $81,000. Northern Trust Corp purchased a new position in Bioceres Crop Solutions in the 4th quarter worth $93,000. Finally, Maven Securities LTD purchased a new position in Bioceres Crop Solutions in the 4th quarter worth $152,000. Institutional investors and hedge funds own 17.68% of the company's stock.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock traded down $0.21 on Monday, hitting $2.50. The company's stock had a trading volume of 631,391 shares, compared to its average volume of 220,670. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. Bioceres Crop Solutions Corp. has a 1 year low of $2.43 and a 1 year high of $10.19. The company has a market capitalization of $156.78 million, a price-to-earnings ratio of -17.82, a price-to-earnings-growth ratio of 1.16 and a beta of 0.43. The firm has a fifty day moving average price of $3.51 and a 200-day moving average price of $4.15.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on BIOX. Brookline Capital Management lowered Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 21st. Wall Street Zen upgraded Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research note on Sunday, August 31st. Finally, Oppenheimer reduced their target price on Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating for the company in a research note on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Bioceres Crop Solutions has an average rating of "Moderate Buy" and an average target price of $8.38.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.